Annual SG&A
$5.66 M
-$3.11 M-35.44%
31 December 2023
Summary:
Processa Pharmaceuticals annual selling, general & administrative expenses is currently $5.66 million, with the most recent change of -$3.11 million (-35.44%) on 31 December 2023. During the last 3 years, it has risen by +$2.39 million (+73.30%). PCSA annual SG&A is now -35.44% below its all-time high of $8.76 million, reached on 31 December 2022.PCSA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.14 M
-$214.30 K-15.86%
30 September 2024
Summary:
Processa Pharmaceuticals quarterly selling, general & administrative expenses is currently $1.14 million, with the most recent change of -$214.30 thousand (-15.86%) on 30 September 2024. Over the past year, it has increased by +$121.40 thousand (+11.95%). PCSA quarterly SG&A is now -61.06% below its all-time high of $2.92 million, reached on 30 September 2022.PCSA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$319.06 M
-$11.53 M-3.75%
30 September 2024
Summary:
Processa Pharmaceuticals TTM selling, general & administrative expenses is currently -$319.06 million, with the most recent change of -$11.53 million (-3.75%) on 30 September 2024. Over the past year, it has dropped by -$326.21 million (-4565.08%). PCSA TTM SG&A is now -12122.21% below its all-time high of $10.06 million, reached on 31 March 2023.PCSA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCSA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.4% | +11.9% | -4565.1% |
| 3 y3 years | +73.3% | -15.0% | -6045.3% |
| 5 y5 years | +293.0% | +171.4% | -10000.0% |
PCSA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -35.4% | +73.3% | -61.1% | +11.9% | -172.3% | at low |
| 5 y | 5 years | -35.4% | +293.0% | -61.1% | +203.4% | -797.5% | at low |
| alltime | all time | -35.4% | +7982.1% | -61.1% | +749.9% | <-9999.0% | at low |
Processa Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.14 M(-15.9%) | $4.91 M(+2.5%) |
| June 2024 | - | $1.35 M(+6.4%) | $4.79 M(+7.3%) |
| Mar 2024 | - | $1.27 M(+10.6%) | $4.46 M(-21.3%) |
| Dec 2023 | $5.66 M(-35.4%) | $1.15 M(+13.1%) | $5.67 M(-20.7%) |
| Sept 2023 | - | $1.02 M(-1.0%) | $7.15 M(-21.0%) |
| June 2023 | - | $1.03 M(-58.6%) | $9.05 M(-10.0%) |
| Mar 2023 | - | $2.48 M(-5.6%) | $10.06 M(+14.8%) |
| Dec 2022 | $8.76 M(+86.9%) | $2.63 M(-10.1%) | $8.76 M(+17.9%) |
| Sept 2022 | - | $2.92 M(+43.5%) | $7.44 M(+27.0%) |
| June 2022 | - | $2.03 M(+71.7%) | $5.86 M(+13.7%) |
| Mar 2022 | - | $1.18 M(-8.7%) | $5.15 M(+10.0%) |
| Dec 2021 | $4.69 M(+43.6%) | $1.30 M(-3.0%) | $4.68 M(-12.8%) |
| Sept 2021 | - | $1.34 M(+0.7%) | $5.37 M(+20.6%) |
| June 2021 | - | $1.33 M(+85.4%) | $4.45 M(+27.3%) |
| Mar 2021 | - | $717.10 K(-63.8%) | $3.50 M(+7.1%) |
| Dec 2020 | $3.26 M(+102.1%) | $1.98 M(+368.6%) | $3.26 M(+94.6%) |
| Sept 2020 | - | $423.00 K(+12.8%) | $1.68 M(+0.2%) |
| June 2020 | - | $374.90 K(-22.6%) | $1.67 M(-2.1%) |
| Mar 2020 | - | $484.40 K(+22.4%) | $1.71 M(+5.3%) |
| Dec 2019 | $1.61 M(+12.2%) | $395.60 K(-5.6%) | $1.62 M(+19.2%) |
| Sept 2019 | - | $419.00 K(+2.2%) | $1.36 M(-2.3%) |
| June 2019 | - | $410.10 K(+3.1%) | $1.39 M(+4.5%) |
| Mar 2019 | - | $397.80 K(+196.6%) | $1.33 M(-5.1%) |
| Dec 2018 | $1.44 M | $134.10 K(-70.3%) | $1.41 M(-26.9%) |
| Sept 2018 | - | $451.40 K(+28.8%) | $1.92 M(+17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $350.60 K(-25.4%) | $1.64 M(+26.3%) |
| Mar 2018 | - | $470.20 K(-27.7%) | $1.29 M(+54.5%) |
| Dec 2017 | $838.30 K(+1097.6%) | $650.60 K(+297.2%) | $838.30 K(+394.6%) |
| Sept 2017 | - | $163.80 K(+1490.3%) | $169.50 K(+1578.2%) |
| June 2017 | - | $10.30 K(-24.3%) | $10.10 K(+225.8%) |
| Mar 2017 | - | $13.60 K(-174.7%) | $3100.00(-95.6%) |
| Dec 2016 | $70.00 K(-92.6%) | -$18.20 K(-513.6%) | $70.00 K(-45.3%) |
| Sept 2016 | - | $4400.00(+33.3%) | $128.00 K(-38.4%) |
| June 2016 | - | $3300.00(-95.9%) | $207.80 K(-63.3%) |
| Mar 2016 | - | $80.50 K(+102.3%) | $566.50 K(-40.1%) |
| Dec 2015 | $945.50 K(-53.2%) | $39.80 K(-52.7%) | $945.40 K(+29.4%) |
| Sept 2015 | - | $84.20 K(-76.7%) | $730.60 K(-44.8%) |
| June 2015 | - | $362.00 K(-21.2%) | $1.32 M(-20.9%) |
| Mar 2015 | - | $459.40 K(-362.5%) | $1.67 M(-17.1%) |
| Dec 2014 | $2.02 M(-28.3%) | -$175.00 K(-125.8%) | $2.02 M(-31.5%) |
| Sept 2014 | - | $677.40 K(-4.9%) | $2.95 M(+0.4%) |
| June 2014 | - | $712.40 K(-11.5%) | $2.93 M(+1.6%) |
| Mar 2014 | - | $805.00 K(+7.0%) | $2.89 M(+2.4%) |
| Dec 2013 | $2.82 M(+49.6%) | $752.10 K(+13.2%) | $2.82 M(+2.8%) |
| Sept 2013 | - | $664.40 K(-0.2%) | $2.74 M(+5.6%) |
| June 2013 | - | $665.60 K(-9.6%) | $2.60 M(+16.4%) |
| Mar 2013 | - | $736.60 K(+9.3%) | $2.23 M(+18.4%) |
| Dec 2012 | $1.88 M | $674.10 K(+29.8%) | $1.88 M(+55.7%) |
| Sept 2012 | - | $519.20 K(+72.9%) | $1.21 M(+75.2%) |
| June 2012 | - | $300.30 K(-23.0%) | $690.40 K(+77.0%) |
| Mar 2012 | - | $390.10 K | $390.10 K |
FAQ
- What is Processa Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual SG&A year-on-year change?
- What is Processa Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly SG&A year-on-year change?
- What is Processa Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals TTM SG&A year-on-year change?
What is Processa Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of PCSA is $5.66 M
What is the all time high annual SG&A for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual selling, general & administrative expenses is $8.76 M
What is Processa Pharmaceuticals annual SG&A year-on-year change?
Over the past year, PCSA annual selling, general & administrative expenses has changed by -$3.11 M (-35.44%)
What is Processa Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of PCSA is $1.14 M
What is the all time high quarterly SG&A for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $2.92 M
What is Processa Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, PCSA quarterly selling, general & administrative expenses has changed by +$121.40 K (+11.95%)
What is Processa Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of PCSA is -$319.06 M
What is the all time high TTM SG&A for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high TTM selling, general & administrative expenses is $10.06 M
What is Processa Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, PCSA TTM selling, general & administrative expenses has changed by -$326.21 M (-4565.08%)